← Open Payments lookup

MARSHALL LAUER: Open Payments

NPI 1306800859 · COLLINGSWOOD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,044 in 93 payments from 17 companies in 2025. Trend: 2023 $1,627 · 2024 $2,206 · 2025 $2,044

Food & beverage: $2,044
CompanyPaymentsAmount
Bayer Healthcare Pharmaceuticals Inc.14$561
Novo Nordisk Inc12$306
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)19$246
Kowa Pharmaceuticals America, Inc.4$168
ABBVIE INC.11$156
Collegium Pharmaceutical, Inc.9$155
AstraZeneca Pharmaceuticals LP7$144
Astellas Pharma US Inc3$68
IDORSIA PHARMACEUTICALS US INC2$40
Lundbeck LLC2$36

Products named: Kerendia, CAPLYTA, Ozempic, ZORYVE, VRAYLAR, FARXIGA, Belbuca, Veozah.

Industry payments across NJ — which companies pay providers there.